Request Demo
Last update 03 Nov 2026
CAR T-cell therapy(National University Hospital)
Last update 03 Nov 2026
Overview
Basic Info
Drug Type CAR-T |
Synonyms- |
Target |
Action modulators |
Mechanism CD7 modulators(T-cell antigen CD7 modulators) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with CAR T-cell therapy(National University Hospital)NCT05043571
Anti-CD7 Protein Expression Blocker (PEBL) Chimeric-Antigen Receptor (CAR) T-Cell Therapy for Relapsed/ Refractory T-Lineage Acute Lymphoblastic Leukaemia (CARTALL)
100 Clinical Results associated with CAR T-cell therapy(National University Hospital)
Login to view more data
100 Translational Medicine associated with CAR T-cell therapy(National University Hospital)
Login to view more data
100 Patents (Medical) associated with CAR T-cell therapy(National University Hospital)
Login to view more data
100 Deals associated with CAR T-cell therapy(National University Hospital)
Login to view more data
R&D Status
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Not Applicable | - | 110 | ASCT+CAR-T | axqzbmhdyk(zxmpwahaue) = geayshcdyx crzjfgspuc (pclicbnfws ) View more | Positive | 12 May 2026 | |
CAR-T | axqzbmhdyk(zxmpwahaue) = qxcitdvsfm crzjfgspuc (pclicbnfws ) View more | ||||||
Not Applicable | 190 | xbyjdoawcu(kvuggejzin) = pqzyfeipeb yykyzfubsi (qcpiylvybw, 29 - 58) View more | Negative | 25 Apr 2026 | |||
Not Applicable | 1,457 | ewdkqwmljb(shlomqluhm) = cwnuiutbvj itsrdhgrcg (uehhbpajmo, 46 - 58) View more | Positive | 20 Apr 2026 | |||
Not Applicable | 330 | CAR-T therapy (NHL) | ncnqrjpwjn(zftaznxfnu) = yubdxbzhfd lrvxtgfczc (zhibsntdcr ) View more | Positive | 06 Dec 2025 | ||
CAR-T therapy (MM) | ncnqrjpwjn(zftaznxfnu) = pzdamdkgtm lrvxtgfczc (zhibsntdcr ) View more | ||||||
Not Applicable | 343 | CD19-directed CAR T-cell therapy (AYAs) | yvmdmqzwpx(lqkynuhipq) = CRS rates and severity were similar between groups fecvvalfqu (uuzppnpjyw ) View more | Positive | 06 Dec 2025 | ||
CD19-directed CAR T-cell therapy (non-AYAs) | |||||||
Not Applicable | 61 | eryvqurofa(xqybyezmxt) = Patients with MTV > 225.72 mL and TLG > 728.8 g at PET0 had a significantly shorter DoR zhzqpewnas (gwyxfwbpkj ) View more | Positive | 17 Jun 2025 |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free